US Q3 Consumer Health Earnings Preview: Coming Changes Overshadow Current Conditions?

Rather than reflecting what’s coming in the way of spinoffs, leadership, product approvals or deal closings, firms’ July-September results will reveal influences from inflation and supply chain problems. Like manufacturers across industries, US consumer health product firms are dealing with US currency strengthening and potentially driving down revenues through losses in foreign exchange.

The number and variety of pending changes for firms across the US consumer health sector likely have company executives considering future results as much as sales and earnings from the most recent quarter.

Executives with Johnson & Johnson could be thinking that despite all their work to prepare the firm’s consumer health...